ALLY Ally Financial | $33.21
+2.8% | 11/14/2022 | Target Set by | S&P Equity Research | - | | $29.50 | Low | View details for S&P Equity Research rating of Ally Financial (NYSE:ALLY) on 11/14/2022 |
DOW DOW | $30.40
-0.4% | 9/9/2022 | Target Lowered by | S&P Equity Research | - | Buy -> Buy | $70.00 -> $60.00 | N/A | View details for S&P Equity Research rating of DOW (NYSE:DOW) on 9/9/2022 |
SEE Sealed Air | $28.01
+2.6% | 1/7/2021 | Upgraded by | S&P Equity Research | - | Neutral -> Buy | $46.00 -> $54.00 | N/A | View details for S&P Equity Research rating of Sealed Air (NYSE:SEE) on 1/7/2021 |
AVY Avery Dennison | $171.41
+1.2% | 1/7/2021 | Upgraded by | S&P Equity Research | - | Neutral -> Buy | $149.00 -> $181.00 | N/A | View details for S&P Equity Research rating of Avery Dennison (NYSE:AVY) on 1/7/2021 |
ESNT Essent Group | $58.56
+2.7% | 6/1/2020 | Target Lowered by | S&P Equity Research | - | In-Line -> Reduce | $56.00 -> $48.00 | High | View details for S&P Equity Research rating of Essent Group (NYSE:ESNT) on 6/1/2020 |
GPC Genuine Parts | $120.30
+2.8% | 4/8/2020 | Target Lowered by | S&P Equity Research | - | Neutral -> Buy | $85.00 -> $78.00 | High | View details for S&P Equity Research rating of Genuine Parts (NYSE:GPC) on 4/8/2020 |
SCI Service Co. International | $76.39
-0.3% | 3/31/2020 | Target Lowered by | S&P Equity Research | - | Outperform | $53.00 -> $47.00 | High | View details for S&P Equity Research rating of Service Co. International (NYSE:SCI) on 3/31/2020 |
NXPI NXP Semiconductors | $188.14
+3.5% | 1/10/2020 | Target Raised by | S&P Equity Research | - | | $145.00 -> $155.00 | Low | View details for S&P Equity Research rating of NXP Semiconductors (NASDAQ:NXPI) on 1/10/2020 |
ARWR Arrowhead Pharmaceuticals | $14.42
+2.7% | 11/26/2019 | Reiterated by | S&P Equity Research | - | Buy | | Medium | View details for S&P Equity Research rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 11/26/2019 |
BX Blackstone | $137.62
+3.2% | 9/24/2019 | Downgraded by | S&P Equity Research | - | Outperform -> Market Perform | | Medium | View details for S&P Equity Research rating of Blackstone (NYSE:BX) on 9/24/2019 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
GLW Corning | $45.76
+2.2% | 8/1/2019 | Downgraded by | S&P Equity Research | - | Positive -> Neutral | $40.00 -> $30.00 | High | View details for S&P Equity Research rating of Corning (NYSE:GLW) on 8/1/2019 |
RMR The RMR Group | $14.53
-0.5% | 7/1/2019 | Upgraded by | S&P Equity Research | - | Market Perform -> Outperform | $54.00 | High | View details for S&P Equity Research rating of The RMR Group (NASDAQ:RMR) on 7/1/2019 |
GERN Geron | $1.38
-3.5% | 9/27/2018 | Target Lowered by | S&P Equity Research | - | | $2.32 -> $1.80 | High | View details for S&P Equity Research rating of Geron (NASDAQ:GERN) on 9/27/2018 |
AAPL Apple | $205.35
-3.7% | 9/11/2018 | Target Raised by | S&P Equity Research | - | Underweight -> In-Line | $62.50 | High | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/11/2018 |
XOMA XOMA | $24.32
+3.8% | 8/14/2018 | Target Lowered by | S&P Equity Research | - | | $18.74 -> $16.26 | Medium | View details for S&P Equity Research rating of XOMA (NASDAQ:XOMA) on 8/14/2018 |
ARWR Arrowhead Pharmaceuticals | $14.42
+2.7% | 6/18/2018 | Target Lowered by | S&P Equity Research | - | | $13.76 -> $11.68 | Medium | View details for S&P Equity Research rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/18/2018 |
NWBO Northwest Biotherapeutics | $0.30
-0.6% | 5/29/2018 | Target Lowered by | S&P Equity Research | - | | $0.28 -> $0.23 | High | View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 5/29/2018 |
MNKD MannKind | $5.00
+1.0% | 1/25/2018 | Target Lowered by | S&P Equity Research | - | | $3.49 -> $2.77 | High | View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 1/25/2018 |
NVAX Novavax | $6.41
| 1/10/2018 | Target Lowered by | S&P Equity Research | - | | $36.20 -> $27.00 | High | View details for S&P Equity Research rating of Novavax (NASDAQ:NVAX) on 1/10/2018 |
SPY SPDR S&P 500 ETF Trust | $566.76
+1.5% | 12/11/2017 | Initiated by | S&P Equity Research | - | | $3,000.00 | N/A | View details for S&P Equity Research rating of SPDR S&P 500 ETF Trust (NYSEARCA:SPY) on 12/11/2017 |
MVIS MicroVision | $1.10
+0.9% | 11/2/2017 | Target Raised by | S&P Equity Research | - | | $1.75 -> $2.22 | N/A | View details for S&P Equity Research rating of MicroVision (NASDAQ:MVIS) on 11/2/2017 |
MNKD MannKind | $5.00
+1.0% | 5/8/2017 | Target Lowered by | S&P Equity Research | - | | $1.04 -> $0.83 | High | View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 5/8/2017 |
WPRT Westport Fuel Systems | $2.96
+2.4% | 3/24/2017 | Target Lowered by | S&P Equity Research | - | | $10.00 -> $8.80 | Low | View details for S&P Equity Research rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/24/2017 |
BLX Banco Latinoamericano de Comercio Exterior, S. A. | $39.35
+1.9% | 1/20/2017 | Downgraded by | S&P Equity Research | - | Buy -> Hold | | N/A | View details for S&P Equity Research rating of Banco Latinoamericano de Comercio Exterior, S. A. (NYSE:BLX) on 1/20/2017 |
UAL United Airlines | $74.07
+7.1% | 1/19/2017 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of United Airlines (NASDAQ:UAL) on 1/19/2017 |
IPG Interpublic Group of Companies | $25.35
+1.6% | 1/12/2017 | Reiterated by | S&P Equity Research | - | Reduce | | N/A | View details for S&P Equity Research rating of Interpublic Group of Companies (NYSE:IPG) on 1/12/2017 |
NVDA NVIDIA | $114.50
+2.6% | 12/29/2016 | Target Lowered by | S&P Equity Research | - | | $2.25 -> $0.62 | N/A | View details for S&P Equity Research rating of NVIDIA (NASDAQ:NVDA) on 12/29/2016 |
NWBO Northwest Biotherapeutics | $0.30
-0.6% | 12/15/2016 | Target Lowered by | S&P Equity Research | - | | $0.73 -> $0.61 | N/A | View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 12/15/2016 |
LMT Lockheed Martin | $472.14
-1.2% | 12/1/2016 | Upgraded by | S&P Equity Research | Analyst Todd Rosenbluth | Buy | | N/A | View details for S&P Equity Research rating of Lockheed Martin (NYSE:LMT) on 12/1/2016 |
GD General Dynamics | $273.21
+0.6% | 12/1/2016 | Upgraded by | S&P Equity Research | Analyst Todd Rosenbluth | Buy | | N/A | View details for S&P Equity Research rating of General Dynamics (NYSE:GD) on 12/1/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 11/18/2016 | Target Lowered by | S&P Equity Research | - | | | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 11/18/2016 |
WELL Welltower | $150.48
+0.1% | 11/3/2016 | Reiterated by | S&P Equity Research | - | Positive | | N/A | View details for S&P Equity Research rating of Welltower (NYSE:WELL) on 11/3/2016 |
TSLA Tesla | $287.21
+2.4% | 10/27/2016 | Reiterated by | S&P Equity Research | - | Sell | | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 10/27/2016 |
OMER Omeros | $7.17
+2.1% | 10/17/2016 | Target Raised by | S&P Equity Research | - | | $7.65 -> $8.63 | N/A | View details for S&P Equity Research rating of Omeros (NASDAQ:OMER) on 10/17/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 10/6/2016 | Target Raised by | S&P Equity Research | - | | $1.07 -> $1.20 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 10/6/2016 |
EXEL Exelixis | $39.60
+1.8% | 9/28/2016 | Target Raised by | S&P Equity Research | - | | $13.41 -> $15.57 | N/A | View details for S&P Equity Research rating of Exelixis (NASDAQ:EXEL) on 9/28/2016 |
GIS General Mills | $55.42
-0.3% | 9/27/2016 | Reiterated by | S&P Equity Research | - | Buy | $70.00 | N/A | View details for S&P Equity Research rating of General Mills (NYSE:GIS) on 9/27/2016 |
BLRX BioLineRx | $3.44
+0.3% | 9/23/2016 | Target Lowered by | S&P Equity Research | - | | $49.60 -> $44.00 | N/A | View details for S&P Equity Research rating of BioLineRx (NASDAQ:BLRX) on 9/23/2016 |
SLS SELLAS Life Sciences Group | $1.74
+7.4% | 9/20/2016 | Target Lowered by | S&P Equity Research | - | | $19.50 -> $17.00 | N/A | View details for S&P Equity Research rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 9/20/2016 |
NVAX Novavax | $6.41
| 9/16/2016 | Target Lowered by | S&P Equity Research | - | | $28.80 -> $23.40 | N/A | View details for S&P Equity Research rating of Novavax (NASDAQ:NVAX) on 9/16/2016 |
Gold Alert: The Truth About Fort Knox Is Coming (Ad) Owning physical gold isn’t the best way to profit.
I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher.
If you wait for the news to hit, you’ll already be too late. Click here now before the biggest gold run in decades kicks off. |
MBOT Microbot Medical | $2.39
-1.2% | 9/14/2016 | Target Lowered by | S&P Equity Research | - | | $1.57 -> $1.31 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 9/14/2016 |
NWBO Northwest Biotherapeutics | $0.30
-0.6% | 9/13/2016 | Target Lowered by | S&P Equity Research | - | | $0.59 -> $0.43 | N/A | View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 9/13/2016 |
XLF Financial Select Sector SPDR Fund | $49.76
+2.1% | 9/8/2016 | Reiterated by | S&P Equity Research | - | Overweight | | N/A | View details for S&P Equity Research rating of Financial Select Sector SPDR Fund (NYSEARCA:XLF) on 9/8/2016 |
AAPL Apple | $205.35
-3.7% | 9/8/2016 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Strong-Buy | | N/A | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/8/2016 |
DVAX Dynavax Technologies | $11.33
-1.3% | 9/2/2016 | Target Raised by | S&P Equity Research | - | | $11.28 -> $16.01 | N/A | View details for S&P Equity Research rating of Dynavax Technologies (NASDAQ:DVAX) on 9/2/2016 |
MNKD MannKind | $5.00
+1.0% | 8/31/2016 | Target Lowered by | S&P Equity Research | - | | $0.84 -> $0.70 | N/A | View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 8/31/2016 |
BAC Bank of America | $41.08
+2.3% | 8/31/2016 | Reiterated by | S&P Equity Research | - | Buy | $18.00 | N/A | View details for S&P Equity Research rating of Bank of America (NYSE:BAC) on 8/31/2016 |
KPTI Karyopharm Therapeutics | $7.36
+8.9% | 8/30/2016 | Target Lowered by | S&P Equity Research | - | | $135.90 -> $113.25 | N/A | View details for S&P Equity Research rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 8/30/2016 |
NFLX Netflix | $1,156.49
+2.0% | 8/25/2016 | Reiterated by | S&P Equity Research | - | Buy | $128.00 | N/A | View details for S&P Equity Research rating of Netflix (NASDAQ:NFLX) on 8/25/2016 |
TGTX TG Therapeutics | $43.44
-4.3% | 8/24/2016 | Target Lowered by | S&P Equity Research | - | | $7.15 -> $6.40 | N/A | View details for S&P Equity Research rating of TG Therapeutics (NASDAQ:TGTX) on 8/24/2016 |
AMAT Applied Materials | $155.10
+4.1% | 8/21/2016 | Target Set by | S&P Equity Research | Analyst angelo zino | Hold | $31.00 | N/A | View details for S&P Equity Research rating of Applied Materials (NASDAQ:AMAT) on 8/21/2016 |
CHKAQ Chesapeake Energy | $3.05
| 8/18/2016 | Reiterated by | S&P Equity Research | - | Hold | | N/A | View details for S&P Equity Research rating of Chesapeake Energy (OTCMKTS:CHKAQ) on 8/18/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 8/16/2016 | Target Lowered by | S&P Equity Research | - | | $1.77 -> $0.45 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 8/16/2016 |
TELL Tellurian | $1.00
+0.2% | 8/8/2016 | Target Lowered by | S&P Equity Research | - | | $4.00 -> $3.40 | N/A | View details for S&P Equity Research rating of Tellurian (NYSEAMERICAN:TELL) on 8/8/2016 |
FSLR First Solar | $130.54
+3.1% | 8/5/2016 | Downgraded by | S&P Equity Research | - | Buy -> Hold | $75.00 -> $55.00 | N/A | View details for S&P Equity Research rating of First Solar (NASDAQ:FSLR) on 8/5/2016 |
GILD Gilead Sciences | $103.68
+0.4% | 7/27/2016 | Reiterated by | S&P Equity Research | - | Strong-Buy | | N/A | View details for S&P Equity Research rating of Gilead Sciences (NASDAQ:GILD) on 7/27/2016 |
T AT&T | $27.63
0.0% | 7/24/2016 | Target Set by | S&P Equity Research | Analyst Angelo Zino | Buy | $46.00 | N/A | View details for S&P Equity Research rating of AT&T (NYSE:T) on 7/24/2016 |
VNQ Vanguard Real Estate ETF | $89.71
+1.2% | 7/25/2016 | Reiterated by | S&P Equity Research | - | Equal Weight | | N/A | View details for S&P Equity Research rating of Vanguard Real Estate ETF (NYSEARCA:VNQ) on 7/25/2016 |
TSLA Tesla | $287.21
+2.4% | 7/24/2016 | Upgraded by | S&P Equity Research | Analyst Efraim Levy | Sell -> Hold | $13.33 | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 7/24/2016 |
HSY Hershey | $163.10
-2.4% | 7/5/2016 | Upgraded by | S&P Equity Research | - | Hold -> Buy | $94.00 -> $126.00 | N/A | View details for S&P Equity Research rating of Hershey (NYSE:HSY) on 7/5/2016 |
SLS SELLAS Life Sciences Group | $1.74
+7.4% | 7/1/2016 | Target Lowered by | S&P Equity Research | - | | $30.50 -> $25.00 | N/A | View details for S&P Equity Research rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 7/1/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 6/24/2016 | Target Lowered by | S&P Equity Research | - | | $0.39 -> $0.33 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 6/24/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 6/17/2016 | Target Lowered by | S&P Equity Research | - | | $0.42 -> $0.35 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 6/17/2016 |
MBI MBIA | $4.83
+3.9% | 6/15/2016 | Reiterated by | S&P Equity Research | - | Positive | | N/A | View details for S&P Equity Research rating of MBIA (NYSE:MBI) on 6/15/2016 |
BHC Bausch Health Companies | $5.42
+2.2% | 5/29/2016 | Reiterated by | S&P Equity Research | Analyst Jeffrey Loo | Buy | | N/A | View details for S&P Equity Research rating of Bausch Health Companies (NYSE:BHC) on 5/29/2016 |
TSLA Tesla | $287.21
+2.4% | 5/20/2016 | Reiterated by | S&P Equity Research | Analyst Efraim Levy | Sell | | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 5/20/2016 |
FOSL Fossil Group | $1.09
+2.8% | 5/13/2016 | Downgraded by | S&P Equity Research | - | Buy -> Strong Sell | $22.00 | N/A | View details for S&P Equity Research rating of Fossil Group (NASDAQ:FOSL) on 5/13/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 5/11/2016 | Target Lowered by | S&P Equity Research | - | | $3.59 -> $2.99 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 5/11/2016 |
ABT Abbott Laboratories | $132.92
+1.6% | 4/30/2016 | Reiterated by | S&P Equity Research | Analyst Jeffrey Loo | Hold | | N/A | View details for S&P Equity Research rating of Abbott Laboratories (NYSE:ABT) on 4/30/2016 |
F Ford Motor | $10.28
+1.0% | 5/1/2016 | Reiterated by | S&P Equity Research | Analyst Efraim Levy | Strong-Buy | $18.00 | N/A | View details for S&P Equity Research rating of Ford Motor (NYSE:F) on 5/1/2016 |
MBOT Microbot Medical | $2.39
-1.2% | 4/27/2016 | Target Lowered by | S&P Equity Research | - | | $3.72 -> $3.24 | N/A | View details for S&P Equity Research rating of Microbot Medical (NASDAQ:MBOT) on 4/27/2016 |
PG Procter & Gamble | $160.59
+0.4% | 4/27/2016 | Reiterated by | S&P Equity Research | - | Hold | $85.00 | N/A | View details for S&P Equity Research rating of Procter & Gamble (NYSE:PG) on 4/27/2016 |
AAPL Apple | $205.35
-3.7% | 4/23/2016 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Buy | | N/A | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 4/23/2016 |
PFE Pfizer | $24.19
+1.1% | 4/12/2016 | Reiterated by | S&P Equity Research | Analyst Jeffrey Loo | Buy | | N/A | View details for S&P Equity Research rating of Pfizer (NYSE:PFE) on 4/12/2016 |
AAPL Apple | $205.35
-3.7% | 3/31/2016 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Buy | | N/A | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 3/31/2016 |
CAKE Cheesecake Factory | $50.31
+4.5% | 3/31/2016 | Reiterated by | S&P Equity Research | - | Hold | $53.00 | N/A | View details for S&P Equity Research rating of Cheesecake Factory (NASDAQ:CAKE) on 3/31/2016 |
ITV ITV | GBX 80
-1.4% | 3/28/2016 | Target Raised by | S&P Equity Research | - | Buy | GBX 200 -> GBX 240 | N/A | View details for S&P Equity Research rating of ITV (LON:ITV) on 3/28/2016 |
TSLA Tesla | $287.21
+2.4% | 3/24/2016 | Downgraded by | S&P Equity Research | - | Hold -> Sell | $10.33 | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 3/24/2016 |
BHC Bausch Health Companies | $5.42
+2.2% | 3/16/2016 | Reiterated by | S&P Equity Research | - | Buy | $90.00 -> $30.00 | N/A | View details for S&P Equity Research rating of Bausch Health Companies (NYSE:BHC) on 3/16/2016 |
NWBO Northwest Biotherapeutics | $0.30
-0.6% | 2/29/2016 | Target Raised by | S&P Equity Research | - | | $1.80 -> $2.10 | N/A | View details for S&P Equity Research rating of Northwest Biotherapeutics (OTCMKTS:NWBO) on 2/29/2016 |
BRK.B Berkshire Hathaway | $540.05
+1.9% | 2/22/2016 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Berkshire Hathaway (NYSE:BRK.B) on 2/22/2016 |
BRK.A Berkshire Hathaway | $809,350.00
+1.8% | 2/23/2016 | Reiterated by | S&P Equity Research | - | Buy | $157.00 | N/A | View details for S&P Equity Research rating of Berkshire Hathaway (NYSE:BRK.A) on 2/23/2016 |
AMAT Applied Materials | $155.10
+4.1% | 2/19/2016 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Hold | | N/A | View details for S&P Equity Research rating of Applied Materials (NASDAQ:AMAT) on 2/19/2016 |
BEI Beiersdorf Aktiengesellschaft | €124.00
+1.1% | 2/18/2016 | Target Set by | S&P Equity Research | - | Neutral | €85.00 | N/A | View details for S&P Equity Research rating of Beiersdorf Aktiengesellschaft (ETR:BEI) on 2/18/2016 |
HEI Heidelberg Materials | €174.25
+0.5% | 2/16/2016 | Target Set by | S&P Equity Research | - | Neutral | €70.00 | N/A | View details for S&P Equity Research rating of Heidelberg Materials (ETR:HEI) on 2/16/2016 |
RBGLY Reckitt Benckiser Group | $13.46
+4.3% | 2/15/2016 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Reckitt Benckiser Group (OTCMKTS:RBGLY) on 2/15/2016 |
CBK Commerzbank | €23.22
-3.3% | 2/12/2016 | Target Set by | S&P Equity Research | - | Buy | €8.00 | N/A | View details for S&P Equity Research rating of Commerzbank (ETR:CBK) on 2/12/2016 |
BA Boeing | $185.49
+1.4% | 2/12/2016 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Boeing (NYSE:BA) on 2/12/2016 |
GLEN Glencore | GBX 246.90
+1.0% | 2/11/2016 | Target Set by | S&P Equity Research | - | Sell | GBX 65 | N/A | View details for S&P Equity Research rating of Glencore (LON:GLEN) on 2/11/2016 |
DIS Walt Disney | $92.52
+1.9% | 2/10/2016 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Walt Disney (NYSE:DIS) on 2/10/2016 |
Gold Alert: The Truth About Fort Knox Is Coming (Ad) Owning physical gold isn’t the best way to profit.
I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher.
If you wait for the news to hit, you’ll already be too late. Click here now before the biggest gold run in decades kicks off. |
MRK Merck & Co., Inc. | $83.14
-0.1% | 2/5/2016 | Reiterated by | S&P Equity Research | - | Hold | $56.00 | N/A | View details for S&P Equity Research rating of Merck & Co., Inc. (NYSE:MRK) on 2/5/2016 |
MT ArcelorMittal | $30.64
+3.2% | 2/5/2016 | Target Set by | S&P Equity Research | - | Sell | $9.60 | N/A | View details for S&P Equity Research rating of ArcelorMittal (NYSE:MT) on 2/5/2016 |
DAI Daimler | €63.08
| 2/4/2016 | Target Set by | S&P Equity Research | - | Buy | €77.00 | N/A | View details for S&P Equity Research rating of Daimler (ETR:DAI) on 2/4/2016 |
AZN AstraZeneca | £107.17
+1.0% | 2/4/2016 | Target Set by | S&P Equity Research | - | Neutral | GBX 4,500 | N/A | View details for S&P Equity Research rating of AstraZeneca (LON:AZN) on 2/4/2016 |
BBVA Banco Bilbao Vizcaya Argentaria | $13.90
+0.9% | 2/4/2016 | Target Set by | S&P Equity Research | - | Neutral | $6.00 | N/A | View details for S&P Equity Research rating of Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) on 2/4/2016 |
GILD Gilead Sciences | $103.68
+0.4% | 2/3/2016 | Initiated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Gilead Sciences (NASDAQ:GILD) on 2/3/2016 |
BT.A BT Group | GBX 171.05
-0.8% | 2/1/2016 | Target Set by | S&P Equity Research | - | Sell | GBX 475 | N/A | View details for S&P Equity Research rating of BT Group (LON:BT.A) on 2/1/2016 |
AMZN Amazon.com | $189.98
-0.1% | 1/28/2016 | Reiterated by | S&P Equity Research | Analyst Tuna Amobi | Buy | $34.25 | N/A | View details for S&P Equity Research rating of Amazon.com (NASDAQ:AMZN) on 1/28/2016 |
F Ford Motor | $10.28
+1.0% | 1/28/2016 | Reiterated by | S&P Equity Research | Analyst Efraim Levy | Buy | | N/A | View details for S&P Equity Research rating of Ford Motor (NYSE:F) on 1/28/2016 |
BAS Basf | €44.63
-1.3% | 1/28/2016 | Target Set by | S&P Equity Research | - | Sell | €57.00 | N/A | View details for S&P Equity Research rating of Basf (ETR:BAS) on 1/28/2016 |
SZG Salzgitter | €21.72
-0.7% | 1/28/2016 | Target Set by | S&P Equity Research | - | Sell | €19.00 | N/A | View details for S&P Equity Research rating of Salzgitter (ETR:SZG) on 1/28/2016 |
MNKD MannKind | $5.00
+1.0% | 1/27/2016 | Target Lowered by | S&P Equity Research | - | | $1.12 -> $0.96 | N/A | View details for S&P Equity Research rating of MannKind (NASDAQ:MNKD) on 1/27/2016 |
EZJ easyJet | GBX 524
+1.8% | 1/27/2016 | Upgraded by | S&P Equity Research | - | Buy | GBX 1,900 | N/A | View details for S&P Equity Research rating of easyJet (LON:EZJ) on 1/27/2016 |
SIE Siemens Aktiengesellschaft | €201.95
-0.1% | 1/26/2016 | Target Set by | S&P Equity Research | - | Neutral | €94.00 | N/A | View details for S&P Equity Research rating of Siemens Aktiengesellschaft (ETR:SIE) on 1/26/2016 |
SAP SAP | €255.30
+0.3% | 1/22/2016 | Target Set by | S&P Equity Research | - | Buy | €76.00 | N/A | View details for S&P Equity Research rating of SAP (ETR:SAP) on 1/22/2016 |
BHP BHP Group | GBX 1,827.50
+1.6% | 1/21/2016 | Reiterated by | S&P Equity Research | - | Hold | GBX 700 | N/A | View details for S&P Equity Research rating of BHP Group (LON:BHP) on 1/21/2016 |
RIO Rio Tinto Group | GBX 4,502
+1.6% | 1/19/2016 | Target Set by | S&P Equity Research | - | Neutral | GBX 1,800 | N/A | View details for S&P Equity Research rating of Rio Tinto Group (LON:RIO) on 1/19/2016 |
TA TransAlta | C$12.80
+2.2% | 1/18/2016 | Reiterated by | S&P Equity Research | - | Hold | C$8.00 | N/A | View details for S&P Equity Research rating of TransAlta (TSE:TA) on 1/18/2016 |
BHP BHP Group | GBX 1,827.50
+1.6% | 1/15/2016 | Reiterated by | S&P Equity Research | - | Hold | GBX 700 | N/A | View details for S&P Equity Research rating of BHP Group (LON:BHP) on 1/15/2016 |
BEI Beiersdorf Aktiengesellschaft | €124.00
+1.1% | 1/15/2016 | Target Set by | S&P Equity Research | - | Buy | €95.00 | N/A | View details for S&P Equity Research rating of Beiersdorf Aktiengesellschaft (ETR:BEI) on 1/15/2016 |
FSLR First Solar | $130.54
+3.1% | 12/17/2015 | Upgraded by | S&P Equity Research | Analyst Angelo Zino | Buy | | N/A | View details for S&P Equity Research rating of First Solar (NASDAQ:FSLR) on 12/17/2015 |
PFC Petrofac | GBX 3.98
| 12/16/2015 | Reiterated by | S&P Equity Research | - | Buy | GBX 1,000 | N/A | View details for S&P Equity Research rating of Petrofac (LON:PFC) on 12/16/2015 |
MRK Merck & Co., Inc. | $83.14
-0.1% | 12/11/2015 | Target Set by | S&P Equity Research | - | Neutral | $104.00 | N/A | View details for S&P Equity Research rating of Merck & Co., Inc. (NYSE:MRK) on 12/11/2015 |
TKA thyssenkrupp | €10.02
+1.9% | 12/9/2015 | Target Set by | S&P Equity Research | - | Neutral | €21.00 | N/A | View details for S&P Equity Research rating of thyssenkrupp (ETR:TKA) on 12/9/2015 |
XOM Exxon Mobil | $106.20
+0.4% | 12/3/2015 | Reiterated by | S&P Equity Research | Analyst Stewart Glickman | Hold | $95.00 | N/A | View details for S&P Equity Research rating of Exxon Mobil (NYSE:XOM) on 12/3/2015 |
T AT&T | $27.63
0.0% | 12/3/2015 | Reiterated by | S&P Equity Research | - | Buy | $41.00 | N/A | View details for S&P Equity Research rating of AT&T (NYSE:T) on 12/3/2015 |
LIN Linde | €399.20
+1.1% | 12/1/2015 | Target Set by | S&P Equity Research | - | Sell | €135.00 | N/A | View details for S&P Equity Research rating of Linde (ETR:LIN) on 12/1/2015 |
BHP BHP Group | GBX 1,827.50
+1.6% | 11/30/2015 | Target Set by | S&P Equity Research | - | Neutral | GBX 900 | N/A | View details for S&P Equity Research rating of BHP Group (LON:BHP) on 11/30/2015 |
MOH Molina Healthcare | $318.04
+1.6% | 11/26/2015 | Target Lowered by | S&P Equity Research | - | Hold | $32.00 -> $30.00 | N/A | View details for S&P Equity Research rating of Molina Healthcare (NYSE:MOH) on 11/26/2015 |
ALNY Alnylam Pharmaceuticals | $259.39
+1.7% | 11/26/2015 | Downgraded by | S&P Equity Research | - | Buy -> Hold | | N/A | View details for S&P Equity Research rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/26/2015 |
DE Deere & Company | $481.40
+0.3% | 11/25/2015 | Reiterated by | S&P Equity Research | Analyst Jim Corridore | Sell | | N/A | View details for S&P Equity Research rating of Deere & Company (NYSE:DE) on 11/25/2015 |
TKA thyssenkrupp | €10.02
+1.9% | 11/19/2015 | Target Set by | S&P Equity Research | - | Neutral | €21.00 | N/A | View details for S&P Equity Research rating of thyssenkrupp (ETR:TKA) on 11/19/2015 |
SZG Salzgitter | €21.72
-0.7% | 11/12/2015 | Target Set by | S&P Equity Research | - | Sell | €22.00 | N/A | View details for S&P Equity Research rating of Salzgitter (ETR:SZG) on 11/12/2015 |
SIE Siemens Aktiengesellschaft | €201.95
-0.1% | 11/12/2015 | Target Set by | S&P Equity Research | - | Neutral | €100.00 | N/A | View details for S&P Equity Research rating of Siemens Aktiengesellschaft (ETR:SIE) on 11/12/2015 |
MRK Merck & Co., Inc. | $83.14
-0.1% | 11/12/2015 | Target Set by | S&P Equity Research | - | Neutral | $104.00 | N/A | View details for S&P Equity Research rating of Merck & Co., Inc. (NYSE:MRK) on 11/12/2015 |
DPW Ault Global | $0.21
| 11/11/2015 | Target Set by | S&P Equity Research | - | Sell | $25.00 | N/A | View details for S&P Equity Research rating of Ault Global (NYSEAMERICAN:DPW) on 11/11/2015 |
MT ArcelorMittal | $30.64
+3.2% | 11/6/2015 | Target Set by | S&P Equity Research | - | Sell | $14.10 | N/A | View details for S&P Equity Research rating of ArcelorMittal (NYSE:MT) on 11/6/2015 |
HEI Heidelberg Materials | €174.25
+0.5% | 11/6/2015 | Target Set by | S&P Equity Research | - | Buy | €80.00 | N/A | View details for S&P Equity Research rating of Heidelberg Materials (ETR:HEI) on 11/6/2015 |
DTE DTE Energy | $136.35
+0.4% | 11/5/2015 | Target Set by | S&P Equity Research | - | Buy | $19.00 | N/A | View details for S&P Equity Research rating of DTE Energy (NYSE:DTE) on 11/5/2015 |
BEI Beiersdorf Aktiengesellschaft | €124.00
+1.1% | 11/4/2015 | Target Set by | S&P Equity Research | - | Buy | €95.00 | N/A | View details for S&P Equity Research rating of Beiersdorf Aktiengesellschaft (ETR:BEI) on 11/4/2015 |
BMW Bayerische Motoren Werke Aktiengesellschaft | €74.30
-2.9% | 11/3/2015 | Target Set by | S&P Equity Research | - | Neutral | €93.00 | N/A | View details for S&P Equity Research rating of Bayerische Motoren Werke Aktiengesellschaft (ETR:BMW) on 11/3/2015 |
CBK Commerzbank | €23.22
-3.3% | 11/3/2015 | Target Set by | S&P Equity Research | - | Neutral | €11.80 | N/A | View details for S&P Equity Research rating of Commerzbank (ETR:CBK) on 11/3/2015 |
CVS CVS Health | $67.49
-2.8% | 11/3/2015 | Upgraded by | S&P Equity Research | - | Strong-Buy | $121.00 | N/A | View details for S&P Equity Research rating of CVS Health (NYSE:CVS) on 11/3/2015 |
CVS CVS Health | $67.49
-2.8% | 11/2/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | $112.00 | N/A | View details for S&P Equity Research rating of CVS Health (NYSE:CVS) on 11/2/2015 |
CL Colgate-Palmolive | $90.42
-0.3% | 11/2/2015 | Reiterated by | S&P Equity Research | - | Hold | $69.00 | N/A | View details for S&P Equity Research rating of Colgate-Palmolive (NYSE:CL) on 11/2/2015 |
HSBA HSBC | GBX 846.18
+2.6% | 11/2/2015 | Target Set by | S&P Equity Research | - | Buy | GBX 600 | N/A | View details for S&P Equity Research rating of HSBC (LON:HSBA) on 11/2/2015 |
SBUX Starbucks | $84.69
+3.3% | 10/30/2015 | Target Raised by | S&P Equity Research | - | Buy | $65.00 -> $68.00 | N/A | View details for S&P Equity Research rating of Starbucks (NASDAQ:SBUX) on 10/30/2015 |
MA Mastercard | $559.18
+2.3% | 10/30/2015 | Downgraded by | S&P Equity Research | - | Hold | $103.00 | N/A | View details for S&P Equity Research rating of Mastercard (NYSE:MA) on 10/30/2015 |
LHA Deutsche Lufthansa | €6.32
+1.2% | 10/30/2015 | Target Set by | S&P Equity Research | - | Sell | €12.00 | N/A | View details for S&P Equity Research rating of Deutsche Lufthansa (ETR:LHA) on 10/30/2015 |
BAYN Bayer Aktiengesellschaft | €23.03
-0.6% | 10/29/2015 | Target Set by | S&P Equity Research | - | Buy | €147.00 | N/A | View details for S&P Equity Research rating of Bayer Aktiengesellschaft (ETR:BAYN) on 10/29/2015 |
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad) Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). |
FME Fresenius Medical Care | €44.51
+1.8% | 10/29/2015 | Target Set by | S&P Equity Research | - | Neutral | €79.00 | N/A | View details for S&P Equity Research rating of Fresenius Medical Care (ETR:FME) on 10/29/2015 |
WBA Walgreens Boots Alliance | $10.98
+0.5% | 10/29/2015 | Reiterated by | S&P Equity Research | - | Buy | $99.00 | N/A | View details for S&P Equity Research rating of Walgreens Boots Alliance (NASDAQ:WBA) on 10/29/2015 |
AIG American International Group | $83.55
+3.4% | 10/29/2015 | Reiterated by | S&P Equity Research | Analyst Catherine Seifert | Buy | $72.00 | N/A | View details for S&P Equity Research rating of American International Group (NYSE:AIG) on 10/29/2015 |
DPW Ault Global | $0.21
| 10/29/2015 | Target Set by | S&P Equity Research | - | Sell | $25.00 | N/A | View details for S&P Equity Research rating of Ault Global (NYSEAMERICAN:DPW) on 10/29/2015 |
PFE Pfizer | $24.19
+1.1% | 10/28/2015 | Reiterated by | S&P Equity Research | - | Hold | $40.00 | N/A | View details for S&P Equity Research rating of Pfizer (NYSE:PFE) on 10/28/2015 |
DD DuPont de Nemours | $67.33
+1.9% | 10/28/2015 | Downgraded by | S&P Equity Research | - | Sell | | N/A | View details for S&P Equity Research rating of DuPont de Nemours (NYSE:DD) on 10/28/2015 |
VOW3 Volkswagen | €95.44
-2.4% | 10/28/2015 | Target Set by | S&P Equity Research | - | Neutral | €115.00 | N/A | View details for S&P Equity Research rating of Volkswagen (ETR:VOW3) on 10/28/2015 |
BATS British American Tobacco | GBX 3,225
-0.3% | 10/28/2015 | Target Set by | S&P Equity Research | - | Neutral | GBX 4,200 | N/A | View details for S&P Equity Research rating of British American Tobacco (LON:BATS) on 10/28/2015 |
LIN Linde | €399.20
+1.1% | 10/28/2015 | Target Set by | S&P Equity Research | - | Sell | €135.00 | N/A | View details for S&P Equity Research rating of Linde (ETR:LIN) on 10/28/2015 |
PHM PulteGroup | $104.51
+2.6% | 10/27/2015 | Target Raised by | S&P Equity Research | - | Buy | $20.00 -> $22.00 | N/A | View details for S&P Equity Research rating of PulteGroup (NYSE:PHM) on 10/27/2015 |
LYB LyondellBasell Industries | $58.34
+0.1% | 10/27/2015 | Upgraded by | S&P Equity Research | - | Buy | $103.00 | N/A | View details for S&P Equity Research rating of LyondellBasell Industries (NYSE:LYB) on 10/27/2015 |
BAS Basf | €44.63
-1.3% | 10/27/2015 | Target Set by | S&P Equity Research | - | Sell | €65.00 | N/A | View details for S&P Equity Research rating of Basf (ETR:BAS) on 10/27/2015 |
MCD McDonald's | $311.78
-0.6% | 10/23/2015 | Reiterated by | S&P Equity Research | - | Hold | | N/A | View details for S&P Equity Research rating of McDonald’s (NYSE:MCD) on 10/23/2015 |
UNP Union Pacific | $218.34
+2.0% | 10/23/2015 | Reiterated by | S&P Equity Research | - | Buy | $112.00 | N/A | View details for S&P Equity Research rating of Union Pacific (NYSE:UNP) on 10/23/2015 |
DOW DOW | $30.40
-0.4% | 10/23/2015 | Downgraded by | S&P Equity Research | - | Hold | $54.00 -> $51.00 | N/A | View details for S&P Equity Research rating of DOW (NYSE:DOW) on 10/23/2015 |
CAT Caterpillar | $323.74
+3.1% | 10/23/2015 | Downgraded by | S&P Equity Research | - | Sell | $72.00 -> $64.00 | N/A | View details for S&P Equity Research rating of Caterpillar (NYSE:CAT) on 10/23/2015 |
AXP American Express | $277.11
+3.2% | 10/22/2015 | Target Raised by | S&P Equity Research | Analyst Erik Oja | Hold | $80.00 -> $81.00 | N/A | View details for S&P Equity Research rating of American Express (NYSE:AXP) on 10/22/2015 |
DAI Daimler | €63.08
| 10/22/2015 | Target Set by | S&P Equity Research | - | Buy | €95.00 | N/A | View details for S&P Equity Research rating of Daimler (ETR:DAI) on 10/22/2015 |
IBM International Business Machines | $245.49
+2.4% | 10/21/2015 | Target Lowered by | S&P Equity Research | - | Buy | $178.00 -> $168.00 | N/A | View details for S&P Equity Research rating of International Business Machines (NYSE:IBM) on 10/21/2015 |
MS Morgan Stanley | $120.23
+3.0% | 10/21/2015 | Downgraded by | S&P Equity Research | Analyst Ken Leon | Buy | $48.00 -> $38.00 | N/A | View details for S&P Equity Research rating of Morgan Stanley (NYSE:MS) on 10/21/2015 |
HON Honeywell International | $214.13
+1.6% | 10/20/2015 | Reiterated by | S&P Equity Research | - | Hold | $108.00 | N/A | View details for S&P Equity Research rating of Honeywell International (NASDAQ:HON) on 10/20/2015 |
GE GE Aerospace | $207.87
+2.1% | 10/20/2015 | Reiterated by | S&P Equity Research | Analyst Jim Corridore | Buy | $272.00 | N/A | View details for S&P Equity Research rating of GE Aerospace (NYSE:GE) on 10/20/2015 |
SAP SAP | €255.30
+0.3% | 10/20/2015 | Target Set by | S&P Equity Research | - | Buy | €76.00 | N/A | View details for S&P Equity Research rating of SAP (ETR:SAP) on 10/20/2015 |
NUE Nucor | $122.92
+2.7% | 10/19/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | | N/A | View details for S&P Equity Research rating of Nucor (NYSE:NUE) on 10/19/2015 |
AMD Advanced Micro Devices | $98.80
+2.2% | 10/18/2015 | Reiterated by | S&P Equity Research | - | Hold | | N/A | View details for S&P Equity Research rating of Advanced Micro Devices (NASDAQ:AMD) on 10/18/2015 |
SLB Schlumberger | $34.74
+3.0% | 10/16/2015 | Reiterated by | S&P Equity Research | Analyst Sharon Stein | Buy | | N/A | View details for S&P Equity Research rating of Schlumberger (NYSE:SLB) on 10/16/2015 |
WMT Walmart | $98.73
+1.4% | 10/15/2015 | Downgraded by | S&P Equity Research | - | Hold | $20.67 | N/A | View details for S&P Equity Research rating of Walmart (NYSE:WMT) on 10/15/2015 |
BAC Bank of America | $41.08
+2.3% | 10/15/2015 | Target Lowered by | S&P Equity Research | - | Buy | $20.00 -> $18.00 | N/A | View details for S&P Equity Research rating of Bank of America (NYSE:BAC) on 10/15/2015 |
MS Morgan Stanley | $120.23
+3.0% | 10/15/2015 | Reiterated by | S&P Equity Research | Analyst Sharon Stein | Buy | $48.00 -> $38.00 | N/A | View details for S&P Equity Research rating of Morgan Stanley (NYSE:MS) on 10/15/2015 |
KR Kroger | $71.99
-0.3% | 10/15/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | $47.00 | N/A | View details for S&P Equity Research rating of Kroger (NYSE:KR) on 10/15/2015 |
AXP American Express | $277.11
+3.2% | 10/15/2015 | Reiterated by | S&P Equity Research | Analyst Erik Oja | Hold | $80.00 | N/A | View details for S&P Equity Research rating of American Express (NYSE:AXP) on 10/15/2015 |
JNJ Johnson & Johnson | $156.09
+1.1% | 10/15/2015 | Reiterated by | S&P Equity Research | - | Buy | $120.00 | N/A | View details for S&P Equity Research rating of Johnson & Johnson (NYSE:JNJ) on 10/15/2015 |
R Ryder System | $144.82
+4.3% | 10/14/2015 | Reiterated by | S&P Equity Research | - | Buy | $95.00 | N/A | View details for S&P Equity Research rating of Ryder System (NYSE:R) on 10/14/2015 |
GE GE Aerospace | $207.87
+2.1% | 10/14/2015 | Reiterated by | S&P Equity Research | - | Buy | $272.00 | N/A | View details for S&P Equity Research rating of GE Aerospace (NYSE:GE) on 10/14/2015 |
TSLA Tesla | $287.21
+2.4% | 10/13/2015 | Upgraded by | S&P Equity Research | Analyst Efraim Levy | Sell -> Hold | $15.00 | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 10/13/2015 |
SAP SAP | €255.30
+0.3% | 10/13/2015 | Target Set by | S&P Equity Research | - | Buy | €76.00 | N/A | View details for S&P Equity Research rating of SAP (ETR:SAP) on 10/13/2015 |
STX Seagate Technology | $93.07
+3.4% | 10/8/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | | N/A | View details for S&P Equity Research rating of Seagate Technology (NASDAQ:STX) on 10/8/2015 |
FLR Fluor | $35.84
+0.2% | 10/8/2015 | Upgraded by | S&P Equity Research | - | Buy | $53.00 | N/A | View details for S&P Equity Research rating of Fluor (NYSE:FLR) on 10/8/2015 |
PEP PepsiCo | $133.75
+0.1% | 10/7/2015 | Reiterated by | S&P Equity Research | - | Hold | $103.00 | N/A | View details for S&P Equity Research rating of PepsiCo (NASDAQ:PEP) on 10/7/2015 |
RIO Rio Tinto Group | GBX 4,502
+1.6% | 10/1/2015 | Target Lowered by | S&P Equity Research | - | Hold | GBX 2,750 -> GBX 2,400 | N/A | View details for S&P Equity Research rating of Rio Tinto Group (LON:RIO) on 10/1/2015 |
VOW3 Volkswagen | €95.44
-2.4% | 9/30/2015 | Target Set by | S&P Equity Research | - | Neutral | €115.00 | N/A | View details for S&P Equity Research rating of Volkswagen (ETR:VOW3) on 9/30/2015 |
QSR Restaurant Brands International | $66.67
+2.2% | 9/29/2015 | Reiterated by | S&P Equity Research | - | Sector Outperform | $50.00 | N/A | View details for S&P Equity Research rating of Restaurant Brands International (NYSE:QSR) on 9/29/2015 |
AA Alcoa | $25.59
+4.3% | 9/29/2015 | Reiterated by | S&P Equity Research | - | Buy | $15.00 | N/A | View details for S&P Equity Research rating of Alcoa (NYSE:AA) on 9/29/2015 |
NKE NIKE | $58.65
+3.3% | 9/28/2015 | Reiterated by | S&P Equity Research | - | Buy | $68.00 | N/A | View details for S&P Equity Research rating of NIKE (NYSE:NKE) on 9/28/2015 |
F Ford Motor | $10.28
+1.0% | 9/25/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | | N/A | View details for S&P Equity Research rating of Ford Motor (NYSE:F) on 9/25/2015 |
DE Deere & Company | $481.40
+0.3% | 9/25/2015 | Reiterated by | S&P Equity Research | - | Strong Sell | $65.00 | N/A | View details for S&P Equity Research rating of Deere & Company (NYSE:DE) on 9/25/2015 |
CAT Caterpillar | $323.74
+3.1% | 9/25/2015 | Target Lowered by | S&P Equity Research | - | Hold | $86.00 -> $72.00 | N/A | View details for S&P Equity Research rating of Caterpillar (NYSE:CAT) on 9/25/2015 |
TMUS T-Mobile US | $248.88
+0.8% | 9/24/2015 | Reiterated by | S&P Equity Research | - | Hold | $41.00 | N/A | View details for S&P Equity Research rating of T-Mobile US (NASDAQ:TMUS) on 9/24/2015 |
AAPL Apple | $205.35
-3.7% | 9/24/2015 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Strong-Buy | $37.50 | N/A | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/24/2015 |
AZO AutoZone | $3,756.09
+0.6% | 9/23/2015 | Reiterated by | S&P Equity Research | - | Hold | $735.00 | N/A | View details for S&P Equity Research rating of AutoZone (NYSE:AZO) on 9/23/2015 |
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad) Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). |
EXPD Expeditors International of Washington | $112.57
+2.7% | 9/21/2015 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Expeditors International of Washington (NASDAQ:EXPD) on 9/21/2015 |
UPS United Parcel Service | $96.33
+1.8% | 9/21/2015 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of United Parcel Service (NYSE:UPS) on 9/21/2015 |
JCI Johnson Controls International | $89.06
+2.1% | 9/21/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | $64.00 | N/A | View details for S&P Equity Research rating of Johnson Controls International (NYSE:JCI) on 9/21/2015 |
ADBE Adobe | $380.87
+1.7% | 9/21/2015 | Reiterated by | S&P Equity Research | - | Hold | $82.00 | N/A | View details for S&P Equity Research rating of Adobe (NASDAQ:ADBE) on 9/21/2015 |
VOW3 Volkswagen | €95.44
-2.4% | 9/21/2015 | Target Set by | S&P Equity Research | - | Neutral | €133.00 | N/A | View details for S&P Equity Research rating of Volkswagen (ETR:VOW3) on 9/21/2015 |
GM General Motors | $45.27
+0.5% | 9/18/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | $43.00 | N/A | View details for S&P Equity Research rating of General Motors (NYSE:GM) on 9/18/2015 |
ORCL Oracle | $150.77
+3.6% | 9/17/2015 | Reiterated by | S&P Equity Research | - | Hold | $40.00 | N/A | View details for S&P Equity Research rating of Oracle (NYSE:ORCL) on 9/17/2015 |
AAPL Apple | $205.35
-3.7% | 9/17/2015 | Upgraded by | S&P Equity Research | Analyst Angelo Zino | Hold -> Strong-Buy | $37.50 | N/A | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/17/2015 |
BDN Brandywine Realty Trust | $4.05
-0.2% | 9/16/2015 | Reiterated by | S&P Equity Research | - | Buy | $14.00 | N/A | View details for S&P Equity Research rating of Brandywine Realty Trust (NYSE:BDN) on 9/16/2015 |
KR Kroger | $71.99
-0.3% | 9/14/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | $47.00 | N/A | View details for S&P Equity Research rating of Kroger (NYSE:KR) on 9/14/2015 |
AXP American Express | $277.11
+3.2% | 9/14/2015 | Reiterated by | S&P Equity Research | Analyst Erik Oja | Hold | $80.00 | N/A | View details for S&P Equity Research rating of American Express (NYSE:AXP) on 9/14/2015 |
M Macy's | $11.95
+2.5% | 9/11/2015 | Reiterated by | S&P Equity Research | - | Hold | $60.00 | N/A | View details for S&P Equity Research rating of Macy’s (NYSE:M) on 9/11/2015 |
AAPL Apple | $205.35
-3.7% | 9/11/2015 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Hold | $37.50 | N/A | View details for S&P Equity Research rating of Apple (NASDAQ:AAPL) on 9/11/2015 |
UAL United Airlines | $74.07
+7.1% | 9/9/2015 | Reiterated by | S&P Equity Research | Analyst Sahar Wolff | Buy | | N/A | View details for S&P Equity Research rating of United Airlines (NASDAQ:UAL) on 9/9/2015 |
CIEN Ciena | $72.82
+1.9% | 9/8/2015 | Reiterated by | S&P Equity Research | - | Hold | $26.00 | N/A | View details for S&P Equity Research rating of Ciena (NYSE:CIEN) on 9/8/2015 |
BB BlackBerry | $3.48
+3.3% | 9/4/2015 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Hold | | N/A | View details for S&P Equity Research rating of BlackBerry (NYSE:BB) on 9/4/2015 |
CPB Campbell's | $35.86
-0.1% | 9/4/2015 | Target Raised by | S&P Equity Research | - | Sell | $44.00 -> $46.00 | N/A | View details for S&P Equity Research rating of Campbell’s (NASDAQ:CPB) on 9/4/2015 |
UAL United Airlines | $74.07
+7.1% | 9/3/2015 | Reiterated by | S&P Equity Research | - | Strong-Buy | $70.00 | N/A | View details for S&P Equity Research rating of United Airlines (NASDAQ:UAL) on 9/3/2015 |
WU Western Union | $9.72
+0.6% | 9/2/2015 | Upgraded by | S&P Equity Research | - | Hold -> Buy | $22.00 | N/A | View details for S&P Equity Research rating of Western Union (NYSE:WU) on 9/2/2015 |
FCX Freeport-McMoRan | $37.63
+3.4% | 9/1/2015 | Upgraded by | S&P Equity Research | - | Hold | $10.00 -> $12.00 | N/A | View details for S&P Equity Research rating of Freeport-McMoRan (NYSE:FCX) on 9/1/2015 |
AVGO Broadcom | $203.64
+3.2% | 8/28/2015 | Target Set by | S&P Equity Research | - | | $16.50 | N/A | View details for S&P Equity Research rating of Broadcom (NASDAQ:AVGO) on 8/28/2015 |
IBM International Business Machines | $245.49
+2.4% | 8/27/2015 | Upgraded by | S&P Equity Research | - | Hold -> Buy | $178.00 | N/A | View details for S&P Equity Research rating of International Business Machines (NYSE:IBM) on 8/27/2015 |
TOL Toll Brothers | $104.30
+3.1% | 8/26/2015 | Reiterated by | S&P Equity Research | - | Buy | $42.00 | N/A | View details for S&P Equity Research rating of Toll Brothers (NYSE:TOL) on 8/26/2015 |
NFLX Netflix | $1,156.49
+2.0% | 8/25/2015 | Reiterated by | S&P Equity Research | Analyst Tuna Amobi | Buy | $128.00 | N/A | View details for S&P Equity Research rating of Netflix (NASDAQ:NFLX) on 8/25/2015 |
HPQ HP | $25.96
+2.2% | 8/24/2015 | Reiterated by | S&P Equity Research | Analyst Angelo Zino | Buy | | N/A | View details for S&P Equity Research rating of HP (NYSE:HPQ) on 8/24/2015 |
CRM Salesforce | $275.21
+2.2% | 8/24/2015 | Reiterated by | S&P Equity Research | - | Buy | $75.00 | N/A | View details for S&P Equity Research rating of Salesforce (NYSE:CRM) on 8/24/2015 |
ROST Ross Stores | $140.49
+1.1% | 8/24/2015 | Reiterated by | S&P Equity Research | - | Buy | $56.00 | N/A | View details for S&P Equity Research rating of Ross Stores (NASDAQ:ROST) on 8/24/2015 |
DE Deere & Company | $481.40
+0.3% | 8/24/2015 | Reiterated by | S&P Equity Research | - | Sell | $79.00 | N/A | View details for S&P Equity Research rating of Deere & Company (NYSE:DE) on 8/24/2015 |
HAIN The Hain Celestial Group | $3.03
+3.8% | 8/20/2015 | Reiterated by | S&P Equity Research | - | Buy | $76.00 | N/A | View details for S&P Equity Research rating of The Hain Celestial Group (NASDAQ:HAIN) on 8/20/2015 |
LOW Lowe's Companies | $227.18
+2.2% | 8/19/2015 | Reiterated by | S&P Equity Research | Analyst Efraim Levy | Hold | $77.00 | N/A | View details for S&P Equity Research rating of Lowe’s Companies (NYSE:LOW) on 8/19/2015 |
TJX TJX Companies | $129.23
+1.3% | 8/19/2015 | Reiterated by | S&P Equity Research | - | Buy | $42.50 | N/A | View details for S&P Equity Research rating of TJX Companies (NYSE:TJX) on 8/19/2015 |
HD Home Depot | $364.41
+1.7% | 8/19/2015 | Reiterated by | S&P Equity Research | - | Hold | $130.00 | N/A | View details for S&P Equity Research rating of Home Depot (NYSE:HD) on 8/19/2015 |
GE GE Aerospace | $207.87
+2.1% | 8/17/2015 | Reiterated by | S&P Equity Research | Analyst Jim Corridore | Buy | | N/A | View details for S&P Equity Research rating of GE Aerospace (NYSE:GE) on 8/17/2015 |
TSLA Tesla | $287.21
+2.4% | 8/15/2015 | Reiterated by | S&P Equity Research | Analyst Efraim Levy | Sell | $15.00 | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 8/15/2015 |
T AT&T | $27.63
0.0% | 8/14/2015 | Reiterated by | S&P Equity Research | - | Buy | $39.00 | N/A | View details for S&P Equity Research rating of AT&T (NYSE:T) on 8/14/2015 |
WFC Wells Fargo & Company | $73.76
+2.7% | 8/13/2015 | Reiterated by | S&P Equity Research | - | Buy | $62.00 | N/A | View details for S&P Equity Research rating of Wells Fargo & Company (NYSE:WFC) on 8/13/2015 |
FOSL Fossil Group | $1.09
+2.8% | 8/13/2015 | Reiterated by | S&P Equity Research | - | Buy | $70.00 | N/A | View details for S&P Equity Research rating of Fossil Group (NASDAQ:FOSL) on 8/13/2015 |
GOOG Alphabet | $165.81
+1.9% | 8/11/2015 | Reiterated by | S&P Equity Research | - | Hold | $35.75 | N/A | View details for S&P Equity Research rating of Alphabet (NASDAQ:GOOG) on 8/11/2015 |
EOG EOG Resources | $110.87
-0.7% | 8/10/2015 | Reiterated by | S&P Equity Research | - | Buy | $96.00 | N/A | View details for S&P Equity Research rating of EOG Resources (NYSE:EOG) on 8/10/2015 |
TSLA Tesla | $287.21
+2.4% | 8/9/2015 | Downgraded by | S&P Equity Research | Analyst Efraim Levy | Sell | $15.00 | N/A | View details for S&P Equity Research rating of Tesla (NASDAQ:TSLA) on 8/9/2015 |
RIG Transocean | $2.37
+1.3% | 8/7/2015 | Reiterated by | S&P Equity Research | - | Hold | $14.00 | N/A | View details for S&P Equity Research rating of Transocean (NYSE:RIG) on 8/7/2015 |
CPRI Capri | $15.53
+3.2% | 8/7/2015 | Upgraded by | S&P Equity Research | - | Buy | $60.00 -> $50.00 | N/A | View details for S&P Equity Research rating of Capri (NYSE:CPRI) on 8/7/2015 |
APA APA | $16.46
+1.5% | 8/7/2015 | Reiterated by | S&P Equity Research | - | Buy | $56.00 | N/A | View details for S&P Equity Research rating of APA (NASDAQ:APA) on 8/7/2015 |
DIS Walt Disney | $92.52
+1.9% | 8/6/2015 | Reiterated by | S&P Equity Research | - | Buy | $122.00 | N/A | View details for S&P Equity Research rating of Walt Disney (NYSE:DIS) on 8/6/2015 |
K Kellanova | $82.67
-0.2% | 8/5/2015 | Reiterated by | S&P Equity Research | - | Hold | $69.00 | N/A | View details for S&P Equity Research rating of Kellanova (NYSE:K) on 8/5/2015 |
AIG American International Group | $83.55
+3.4% | 8/4/2015 | Reiterated by | S&P Equity Research | - | Buy | $72.00 | N/A | View details for S&P Equity Research rating of American International Group (NYSE:AIG) on 8/4/2015 |
REI.UN RioCan Real Estate Investment Trust | C$17.29
| 8/4/2015 | Reiterated by | S&P Equity Research | - | Sector Perform | | N/A | View details for S&P Equity Research rating of RioCan Real Estate Investment Trust (TSE:REI.UN) on 8/4/2015 |
CVX Chevron | $138.53
+1.7% | 8/1/2015 | Downgraded by | S&P Equity Research | Analyst Stewart Glickman | Hold | $96.00 | N/A | View details for S&P Equity Research rating of Chevron (NYSE:CVX) on 8/1/2015 |
XOM Exxon Mobil | $106.20
+0.4% | 8/1/2015 | Upgraded by | S&P Equity Research | Analyst Stewart Glickman | Hold -> Buy | $90.00 | N/A | View details for S&P Equity Research rating of Exxon Mobil (NYSE:XOM) on 8/1/2015 |
MCK McKesson | $707.28
+0.1% | 7/31/2015 | Reiterated by | S&P Equity Research | - | Buy | $268.00 | N/A | View details for S&P Equity Research rating of McKesson (NYSE:MCK) on 7/31/2015 |
BAX Baxter International | $30.69
+0.1% | 7/31/2015 | Downgraded by | S&P Equity Research | - | Hold | $42.00 | N/A | View details for S&P Equity Research rating of Baxter International (NYSE:BAX) on 7/31/2015 |
AZN AstraZeneca | $72.44
+2.7% | 7/31/2015 | Upgraded by | S&P Equity Research | - | Buy | $38.00 | N/A | View details for S&P Equity Research rating of AstraZeneca (NASDAQ:AZN) on 7/31/2015 |
AZN AstraZeneca | £107.17
+1.0% | 7/31/2015 | Upgraded by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of AstraZeneca (LON:AZN) on 7/31/2015 |
MA Mastercard | $559.18
+2.3% | 7/30/2015 | Reiterated by | S&P Equity Research | - | Buy | $103.00 | N/A | View details for S&P Equity Research rating of Mastercard (NYSE:MA) on 7/30/2015 |
UPS United Parcel Service | $96.33
+1.8% | 7/29/2015 | Reiterated by | S&P Equity Research | - | Buy | $120.00 | N/A | View details for S&P Equity Research rating of United Parcel Service (NYSE:UPS) on 7/29/2015 |
META Meta Platforms | $597.02
+4.3% | 7/28/2015 | Reiterated by | S&P Equity Research | - | Buy | | N/A | View details for S&P Equity Research rating of Meta Platforms (NASDAQ:META) on 7/28/2015 |
CMI Cummins | $299.72
+1.6% | 7/28/2015 | Reiterated by | S&P Equity Research | Analyst Jim Corridore | Buy | $180.00 | N/A | View details for S&P Equity Research rating of Cummins (NYSE:CMI) on 7/28/2015 |
V Visa | $347.66
+1.5% | 7/28/2015 | Downgraded by | S&P Equity Research | Analyst Erik Oja | Hold | $80.00 | N/A | View details for S&P Equity Research rating of Visa (NYSE:V) on 7/28/2015 |
SBUX Starbucks | $84.69
+3.3% | 7/28/2015 | Upgraded by | S&P Equity Research | - | Buy | $65.00 | N/A | View details for S&P Equity Research rating of Starbucks (NASDAQ:SBUX) on 7/28/2015 |
UAA Under Armour | $6.00
+3.4% | 7/24/2015 | Upgraded by | S&P Equity Research | - | Buy | $110.00 | N/A | View details for S&P Equity Research rating of Under Armour (NYSE:UAA) on 7/24/2015 |
